CONSULTANT HAEMATOLOGIST
Dr Shahla Vilcassim
MBBchBAO FRACP FRPCA
Dr Shahla Vilcassim is a Haematologist at Monash Medical Centre, as well as at St John of God Berwick. She completed her undergraduate studies at University College Dublin, Ireland where she was awarded an MBBchBAO. She undertook her specialty training through Monash Medical Centre and the Alfred Hospital. She is a fellow of both the Royal Australasian College of Physicians (RACP) as well as the Royal College of Pathologists of Australasia (RCPA).
Dr Vilcassim is currently undertaking her PhD studies focusing on the Myelodysplastic Syndromes through Monash University and the Hudson Institute of Medical Research. She was awarded the Monash Health Clinical Academic Fellowship.
Practice Interests
Dr Vilcassim’s clinical and research interests include haematological malignancies (e.g. myelodysplasia) as well as treatment of haemoglobinopathies.
Dr Vilcassim consults out of St John of God Berwick and will see patients with any haematological disorder including haematological malignancies, iron deficiency as well as thrombosis.
Practice Locations
Dr Shahla Vilcassim consults privately in rooms located at St John of God Hospital Consulting Suites, Berwick.
TeleHealth appointments are available.
St John of God Hospital Consulting Suites
Ground Floor
75 Kangan Drive
Berwick VIC 3806
Tel: 03 5910 6100
Fax: 03 5910 6101
Hospital Accreditation
Clinical Interests Include:
Extended Profile
Dr Shahla Vilcassim
– Key Research, Journal & Book Publications, Presentations &/or Awards
Selected Journal Publications (Recent)
- Ong J, Brown S, Gilbertson M, Grigoriadis G, Simpson I, Vilcassim S, Low M, Fedele P, Motorna O, Roberts L, Gingold M, Gregory G. Two cases of refractory IgG4-related disease successfully treated with tocilizumab. Ann Hematol. 2022 Feb 13. doi: 10.1007/s00277-022-04787-x. Epub ahead of print.
- Vadolas J, Ng GZ, Kysenius K, Crouch PJ, Dames S, Eisermann M, Nualkaew T, Vilcassim S, Schaeper U, Grigoriadis G. SLN124, a GalNac-siRNA targeting transmembrane serine protease 6, in combination with deferiprone therapy reduces ineffective erythropoiesis and hepatic iron-overload in a mouse model of β-thalassaemia. Br J Haematol. 2021 Jul;194(1):200-210. doi: 10.1111/bjh.17428. Epub 2021 May 4.
- Tedjaseputra A, Vilcassim FS, Grigoriadis G. Ocular infiltration as initial presentation of acute monocytic leukaemia transformed from chronic myelomonocytic leukaemia associated with BRAF V600E mutation. BMJ Case Rep. 2019 Mar 31;12(3):e228519.
- Chee A, Low MS, Vilcassim S, Gregory GP, Gilbertson M, Ratnasingam S, Grigoriadis G, Fedele PL. Failure to achieve early disease response is associated with inferior survival in patients with newly diagnosed multiple myeloma. Br J Haematol. 2018 Sep;182(5):739-741. doi: 10.1111/bjh.14871. Epub 2017 Aug 31.
- Vilcassim FS, Low M, Fedele P, Grigoriadis G. Periorbital papules as a presenting sign in multiple myeloma with AL amyloidosis. BMJ Case Rep. 2017 Feb 20;2017
Professional Memberships
Fellow of the Royal College of Pathologists of Australia (FRCPA)
Fellow of Royal Australasian College of Physicians (FRACP)
